Hareeprasad Vongooru, MD
Advanced Heart Failure and Transplant Cardiology · Edgewood, KYNPI 1407045693
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.5%), food and beverage and education — rather than concentrated in one kind of arrangement. Abbott accounts for 73.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $3,163 and has fallen 87.9% since, to $381 in 2025.
Across 98 payments — averaging $86.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Pfizer$414
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$365
- AstraZeneca$364
- E.r. Squibb & Sons, L.L.C.$260
- Impulse Dynamics (USA) Inc.$171
- plus $648 from 10 others
Across 12 payments — averaging $11,462 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$138K
What the payments were for
- Travel & lodging$4,61654%
- Food & beverage$3,84745%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 61 | $6,255 |
| Pfizer | 5 | $414 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $365 |
| AstraZeneca | 5 | $364 |
| E.r. Squibb & Sons, L.L.C. | 4 | $260 |
| Impulse Dynamics (USA) Inc. | 1 | $171 |
| Daxor Corporation | 2 | $149 |
| Abiomed | 2 | $118 |
| Medtronic | 1 | $117 |
| Boston Scientific | 3 | $117 |
| Johnson & Johnson | 1 | $39 |
| Boehringer Ingelheim | 1 | $33 |
| Livanova USA, Inc. | 1 | $24 |
| Getinge USA Sales, LLC | 1 | $21 |
| Bayer | 1 | $17 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,547
- Mitra Clip system$1,308
- MitraClip System$1,216
- OPTIMIZER$343
- LifeVest$209
- BVA-100$124
- VYNDAQEL$120
- Reveal LINQ$117
How this compares
Too few advanced heart failure and transplant cardiology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AdempasRiociguat | 16 | $226,600 |
| EntrestoSacubitril/Valsartan | 11 | $12,151 |
| Torsemide | 12 | $241 |
| Metoprolol Succinate | 14 | $209 |
| Spironolactone | 23 | $202 |
| Warfarin Sodium | 35 | $172 |
| Carvedilol | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerAdempas | $17 | $226,60016 claims |
| NovartisEntresto | $14 | $12,15111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few advanced heart failure and transplant cardiology providers in Kentuckyon file to place this against a meaningful peer group, so we don't.
Other advanced heart failure and transplant cardiology in Edgewood
- Amaninderapal GhotraEdgewood$8K
- Keerthy NarisettyEdgewood$5K
- Sudha JaganathanEdgewood$4K
- Deepthi MosaliEdgewood$3K
- Timothy RaymondFt Wright$88K
- Chioma ObiokoyeLouisville$14K
- Sonu AbrahamLexington$13K
- Marciano LeeLexington$11K
- Andrew KolodziejLexington$7K
- Navin RajagopalanLexington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.